|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8,160.00 VND | -4.00% |
|
0.00% | -19.21% |
| 06-08 | SPM Corporation Provides Earnings Guidance for the Year 2026 | CI |
| 04-20 | SPM Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| Market Cap | 112B 4.27M 3.76M 3.47M 3.24M 6.07M 402M 6.19M 41.64M 16.13M 198M 16.02M 15.67M 690M | P/E 2024 |
33.4x | P/E 2025 | -82x |
|---|---|---|---|---|---|
| Enterprise Value | 182B 6.9M 6.08M 5.6M 5.24M 9.82M 650M 10M 67.35M 26.09M 321M 25.91M 25.35M 1.12B | EV / Sales 2024 |
0.9x | EV / Sales 2025 | 0.82x |
| Free-Float |
17.73% | Yield 2024 |
4.46% | Yield 2025 | - |
| 1 day | -4.00% | ||
| Current month | -13.19% | ||
| 1 month | -8.83% | ||
| 3 months | -7.27% | ||
| 6 months | -16.73% | ||
| Current year | -19.21% |
| 1 month | 8,100 |  | 9,400 |
| Current year | 8,100 | | 10,400 |
| 1 year | 8,100 | | 11,700 |
| 3 years | 8,100 | | 15,100 |
| 5 years | 8,100 | | 34,500 |
| 10 years | 8,100 | | 34,500 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ky The Nguyen
CEO | Chief Executive Officer | 82 | 30/06/2010 |
Chien Tat Van
PRN | Corporate Officer/Principal | 60 | - |
Nhan Thanh Vo
AUD | Comptroller/Controller/Auditor | - | 01/06/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Ky The Nguyen
BRD | Director/Board Member | 82 | 01/01/1990 |
Hoang Huu Dao
CHM | Chairman | 63 | 30/06/2010 |
Khoi Huu Dao
BRD | Director/Board Member | 52 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.00% | 0.00% | -25.82% | -41.71% | 4.28M | |
| +0.92% | +0.47% | +43.59% | +143.50% | 987B | |
| +0.80% | +2.90% | +58.35% | +45.64% | 576B | |
| +0.06% | +6.17% | +26.59% | +72.81% | 415B | |
| +0.25% | -2.44% | +22.01% | +15.66% | 320B | |
| +0.75% | +2.76% | +30.31% | +37.10% | 279B | |
| +2.35% | +3.25% | +34.63% | +21.78% | 278B | |
| +1.23% | +9.11% | -31.23% | -42.75% | 208B | |
| +1.27% | +2.86% | +26.65% | +54.74% | 187B | |
| +0.09% | -0.23% | +16.75% | +61.56% | 155B | |
| Average | +0.37% | +1.20% | +20.18% | +36.83% | 340.52B | |
| Weighted average by Cap. | +0.83% | +2.25% | +33.45% | +67.69% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 298B 11.31M 9.96M 9.18M 8.59M 16.09M 1.07B 16.39M 110M 42.75M 526M 42.46M 41.54M 1.83B | 254B 9.64M 8.49M 7.83M 7.32M 13.72M 909M 13.98M 94.12M 36.46M 448M 36.21M 35.42M 1.56B |
| Net income | 4.62B 175K 154K 142K 133K 250K 16.53M 254K 1.71M 663K 8.15M 658K 644K 28.37M | -1.7B -64.43K -56.73K -52.32K -48.94K -91.69K -6.07M -93.4K -629K -244K -3M -242K -237K -10.42M |
| Net Debt | 112B 4.27M 3.76M 3.47M 3.24M 6.08M 403M 6.19M 41.69M 16.15M 199M 16.04M 15.69M 691M | 69.36B 2.63M 2.32M 2.14M 2M 3.75M 248M 3.82M 25.71M 9.96M 122M 9.89M 9.67M 426M |
Employees
250
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|
- Stock Market
- Stocks
- SPM Stock
Select your edition
All financial news and data tailored to specific country editions
